相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides
Gregory M. Laird et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Gerrit Gehring et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Ebola Virus Disease in West Africa - The First 9 Months of the Epidemic and Forward Projections
Bruce Aylward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
INFECTIOUS DISEASE Ebola vaccine: Little and late
Jon Cohen
SCIENCE (2014)
Identification of repurposed small molecule drugs for chordoma therapy
Menghang Xia et al.
CANCER BIOLOGY & THERAPY (2013)
The potential of sunitinib as a therapy in ovarian cancer
Umberto Leone Roberti Maggiore et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
Charles J. Shoemaker et al.
PLOS ONE (2013)
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Peter B. Madrid et al.
PLOS ONE (2013)
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Digoxin Suppresses HIV-1 Replication by Altering Viral RNA Processing
Raymond W. Wong et al.
PLOS PATHOGENS (2013)
Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening
Luis Martinez-Gil et al.
PLOS ONE (2012)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition
Osvaldo Martinez et al.
CELLULAR MICROBIOLOGY (2010)
An enzymatic virus-like particle assay for sensitive detection of virus entry
Donna M. Tscherne et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry
Derek Dube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ebola virus uses clathrin-mediated endocytosis as an entry pathway
Suchita Bhattacharyya et al.
VIROLOGY (2010)
Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition
Zhen Wang et al.
CANCER RESEARCH (2009)
Association of Ebola virus matrix protein VP40 with microtubules
G Ruthel et al.
JOURNAL OF VIROLOGY (2005)
Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha
A Yonezawa et al.
JOURNAL OF VIROLOGY (2005)
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen
ER Jang et al.
ONCOGENE (2004)
分享论文
